Actively Recruiting
Study on Central Sensitisation Syndrome in Women Aged 18 to 50 With Endometriosis Evaluating Symptoms and Risk Factors Using a Questionnaire
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-14
310
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the presence and related risk factors of Central Sensitisation Syndrome CSS in women with endometriosis. Endometriosis is a chronic condition where endometrial cells grow outside the uterus, causing symptoms like pelvic pain and discomfort. Since many women with endometriosis experience chronic pelvic pain that may not be fully resolved by hormone therapy or surgery, this study explores how CSS, a condition involving heightened central nervous system sensitivity to pain, might contribute to their symptoms. Participants will complete the Central Sensitisation Inventory CSI questionnaire during their gynecological examination and transvaginal ultrasound check-up. This questionnaire assesses 25 symptoms related to CSS to help diagnose the syndrome. The study focuses on women aged 18 to 50 years who have a clinical, ultrasound, or surgical diagnosis of endometriosis and are starting or already on hormone therapy. During the first visit after enrollment, researchers will measure the prevalence of CSS and analyze the CSI scores in relation to various factors, such as endometriosis symptoms, hormone therapy duration, lesion location, and other clinical characteristics. Participants will be evaluated through standard medical examinations and the CSI questionnaire. The study aims to better understand CSS in women with endometriosis to inform future care approaches.
CONDITIONS
Brief Title
Central Awareness in Women With Endometriosis
Research Team
D
Diego Raimondo, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here